Platelet-rich Plasma, Corticosteroid, or Lidocaine for Acromioclavicular Joint Pain
Stopped early · Phase 4
Conditions studied: Acromioclavicular Sprain
In brief
This study will compare three different treatment injections for the management of acromioclavicular joint dysfunction (ACJ Dysfunction). Patients that consent and enroll will be randomized to receive (1) a corticosteroid injection, (2) an injection of Platelet Rich Plasma, or (3) a Lidocaine injection. Follow-up will occur over a 1 year period.
Key facts
- Study ID
- NCT05161468
- Run by
- Brooke Army Medical Center
- People needed
- 34
- Starts
- 2021-08-12
- Expected to finish
- 2025-05-12
- Last updated by the study team
- 2025-05-14
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- TRICARE eligible beneficiaries (active duty, dependents, and military retired) with a primary complaint of AC joint pain.
- Age 18-65 years
- Able to speak and read English well enough to provide informed consent, follow study instructions and independently answer the questionnaires/surveys.
- Tender to palpation over the AC joint that reproduces the specific pain they are seeking care for
- Provocative test (cross-arm test, pain with push-ups, etc) that reproduces the specific pain they are here to seek care for
You may not qualify if…
- In the last year, the subject received any invasive interventions including injections (corticosteroid, hyaluronic acid, lidocaine, PRP, etc.) or surgery for the affected shoulder - specifically to the AC joint.
- Anyone separating from the military within 10 months (other than normal military retirement), pending a medical evaluation board, discharge from the military for medical reasons, or pending or undergoing any litigation for an injury
- AC Joint separation that are with a severity of Grades III-VI (in most cases, these are treated surgically, although 78% of military surgeons recommended preferring conservative care for Grade III separations, and 86% recommending at least 3 months of conservative care before surgical consideration.
- Systemic Disease that could otherwise be responsible for the shoulder pain (i.e. rheumatoid arthritis, gout, or psoriatic arthritis), non-musculoskeletal conditions causing shoulder pain, personal history of neoplasm, current or recent shoulder joint infection, acute fracture or dislocation of the shoulder related to the current episode of pain, or other more likely primary musculoskeletal shoulder disorders (rotator cuff pathology, bicipital tendonitis, etc.)
- Concurrent adhesive capsulitis of the affected shoulder
- History of intolerance or allergy to corticosteroids
Where it is running
- Brooke Army Medical Center — San Antonio, Texas, United States
- Madigan Army Medical Center — Tacoma, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.